Clinicopathological characteristics and eligibility for adjuvant olaparib of germline BRCA1/2 mutation carriers with HER2-negative early breast cancer

Detalles Bibliográficos

Publicado en:	NPJ Breast Cancer vol. 10, no. 1 (2024), p. 28
Autor principal:	Morganti, Stefania
Otros Autores:	Jin, Qingchun, Vincuilla, Julie, Buehler, Ryan, Ryan, Sean, Stokes, Samantha, Parker, Tonia, Mittendorf, Elizabeth A., King, Tari A., Weiss, Anna, Partridge, Ann H., Bychkovsky, Brittany L., Curigliano, Giuseppe, Tayob, Nabihah, Lin, Nancy U., Garber, Judy E., Tolaney, Sara M., Lynce, Filipa
Publicado:	Nature Publishing Group
Materias:	Genetic testing Oncology Tumors Surgery Cancer therapies Chemotherapy Breast cancer
Acceso en línea:	Citation/Abstract Full Text - PDF
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!